Rocket

Spice

Notable

Raise

<h2 id="quick-summary">Quick Summary</h2>
<ul>
 <li>Stifel Nicolaus maintained its Buy recommendation on RKLB while increasing the price target to $105, suggesting approximately 20.9% potential upside.</li>
 <li>Cantor Fitzgerald kept its Overweight stance with an $85 target, highlighting the company’s record of 84+ successful launches.</li>
 <li>Morgan Stanley previously elevated RKLB to Overweight with a $105 forecast; Citigroup made a similar upgrade to Outperform earlier this year.</li>
 <li>The company finalized its $155.3 million purchase of Mynaric AG, expanding into laser-based optical communication systems.</li>
 <li>Company executives have divested 233,449 shares in the last three months, while institutional investors control 71.78% of outstanding shares.</li>
</ul>
Rocket Lab (RKLB) continues to attract significant interest from Wall Street analysts. On Monday, Stifel Nicolaus reaffirmed its Buy stance while boosting the price objective from $90 to $105, indicating potential upside of approximately 20.9% based on current trading levels.
<a href="https://knockoutstocks.com/stock/RKLB" rel="noopener noreferrer nofollow"> <img src="https://knockoutstocks.com/api/stocks/RKLB/embed" alt="RKLB Stock Card"> Rocket Lab USA, Inc., RKLB </a>
Shares began Monday’s session at $86.87. The stock has experienced remarkable appreciation over the past twelve months, gaining roughly 330%, and remains near its 52-week peak of $99.58.
Cantor Fitzgerald similarly maintained its Overweight designation while holding steady with an $85 price objective. The investment firm emphasized Rocket Lab’s impressive history of over 84 successful missions as a competitive advantage.
Rocket Lab ranks as the second busiest launch provider in the United States, trailing only <a href="https://coincentral.com/spacex-is-coming-to-the-stock-market-but-should-you-buy-in/" rel="noopener noreferrer nofollow">SpaceX</a>. The organization generated $602 million in revenue during the trailing twelve months, representing 38% year-over-year expansion.
Morgan Stanley previously elevated the stock to Overweight in January, establishing a $105 target price. Citigroup subsequently upgraded from Market Perform to Outperform in April.
The analyst community’s overall assessment currently stands at Moderate Buy, with a consensus price objective of $83.31. Among 17 analysts monitored by MarketBeat, two assign Strong Buy ratings, nine recommend Buy, five suggest Hold, and one advises Sell.
Institutional stakeholders control 71.78% of RKLB shares. Vanguard expanded its holdings by 13.4% during Q4, currently maintaining over 47 million shares. Baillie Gifford increased its position by 47.2% throughout the same quarter.
<h2 id="strategic-portfolio-enhancement-at-rocket-lab">Strategic Portfolio Enhancement at Rocket Lab</h2>
On April 14, <a href="https://coincentral.com/rocket-lab-rklb-stock-surges-12-percent-mynaric-deal-gauss-thruster-launch/" rel="noopener noreferrer nofollow">Rocket Lab</a> introduced Gauss at the Space Symposium — an internally developed electric satellite propulsion platform. The system features a Hall thruster, power processing unit, and propellant management assembly, with manufacturing capacity exceeding 200 thrusters annually.
The Gauss platform is designed for commercial and national security satellite networks. This represents part of Rocket Lab’s strategic initiative to diversify beyond launch services and expand its satellite systems capabilities.
Additionally last week, the organization finalized its purchase of Mynaric AG for $155.3 million. The transaction included a minimal cash component and the distribution of approximately 2.28 million Rocket Lab shares, after receiving clearance from Germany’s Federal Ministry for Economic Affairs and Energy. Mynaric contributes laser-based optical communications technology for aerial, space, and mobile applications.
<h2 id="notable-executive-trading-activity">Notable Executive Trading Activity</h2>
Not all stakeholders are accumulating positions. Chief Financial Officer Adam Spice divested 62,744 shares on March 2 at $69.59, decreasing his holdings by 4.61%. Chief Executive Peter Beck sold 18,857 shares on the identical date at the same price, representing a 2.09% reduction.
Collectively, company insiders have sold 233,449 shares during the past three months, totaling approximately $16.5 million in value.
Insiders maintain ownership of 11.90% of the enterprise. The market capitalization stands at $49.46 billion, with a P/E ratio of -233.02 and a beta coefficient of 2.20.
Rocket Lab has also executed a multi-launch contract with iQPS, incorporating three additional Electron missions commencing in 2028. This increases total iQPS missions to 15, with seven successfully completed since 2023.
The post <a href="https://blockonomi.com/rocket-lab-rklb-stock-wall-street-analysts-raise-price-targets-amid-mynaric-acquisition/" rel="noopener noreferrer nofollow">Rocket Lab (RKLB) Stock: Wall Street Analysts Raise Price Targets Amid Mynaric Acquisition</a> appeared first on <a href="https://blockonomi.com" rel="noopener noreferrer nofollow">Blockonomi</a>.

Rocket Lab (RKLB) Stock: Wall Street Analysts Raise Price Targets Amid Mynaric Acquisition

Table of Contents

Blockonomi

Other articles published on Apr 20, 2026

Join our free newsletter for daily crypto updates!